The clinical utility of SUDOSCAN in chronic kidney disease in Chinese patients with type 2 diabetes

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Luk, Andrea O Y ^a,b   Fu, Wai Chi ^a   Li, Xue ^a   Ozaki, Risa ^a,b   Chung, Harriet H Y ^a   Wong, Rebecca Y M ^a,b   So, Wing Yee ^a,b   Chow, Francis C C ^a,b   Chan, Juliana C N ^a,b   Balasubramanyam, Muthuswamy ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHINESE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE DURATION; FEMALE; GALVANIC SKIN RESPONSE SENSOR; GLOMERULUS FILTRATION RATE; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT IDENTIFICATION; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; CHINA; COMPLICATION; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; ELECTRODERMAL RESPONSE; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; SWEAT GLAND;

AGED; AREA UNDER CURVE; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; FEMALE; GALVANIC SKIN RESPONSE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; ROC CURVE; SWEAT GLANDS;

EID: 84943162648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134981     Document Type: Article

References (29)

1. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005; 16: 489-495. PMID: 15590763
2. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006; 17: 2034-2047. PMID: 16738019
3. Whaley-Connell A, Sowers JR, McCullough PA, Roberts T, McFarlane SI, Chen SC, et al. Diabetes mellitus and CKD awareness: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis. 2009; 53(SUPPL. 4): S11-S21.
4. American Diabetes Association. Standards of Medical Care in Diabetes-2014. Diabetes Care. 2014; 37: S14-S80. doi: 10.2337/dc14-S014 PMID: 24357209
5. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358: 580-591. doi: 10.1056/NEJMoa0706245 PMID: 18256393
6. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345: 861-869. PMID: 11565518
7. Frazee LA, Samandari S, Tanphaichitr N, Bourquet CC, Pfister EW. Screening for nephropathy and antiangiotensin use among diabetic patients in an academic community medical center. Am J Ther. 2006; 13: 18-23. PMID: 16428918
8. Schwarz PE, Brunswick P, Calvet JH. EZSCAN a new technology to detect diabetes risk. Br J Diabetes Vasc Dis. 2011; 11: 204-209.
9. Kreyden OP, Scheidegger EP. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin Dermatol. 2004; 22: 40-44. PMID: 15158544
10. Fealey RD, Low PA, Thomas J. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc. 1989; 64: 617-628. PMID: 2747292
11. Yang Z, Xu B, Lu J, Tian X, Li M, Sun K, et al. Autonomic test by EZSCAN in the screening for prediabetes and diabetes. PLoS ONE. 2013; 8(2): e56480. doi: 10.1371/journal.pone.0056480 PMID: 23424665
12. Chen L, Chen X, Ding R, ShiQ Jr, Hu D. Evaluation of EZSCAN as a screening tool for impaired glucose metabolism. Diabetes Res Clin Pract. 2013; 100: 210-214. doi: 10.1016/j.diabres.2013.03.001 PMID: 23529065
13. Ramachandran A, Moses A, Shetty S, Thirupurasundari CJ, Seeli AC, Snehalatha C, et al. A new noninvasive technology to screen for dysglycaemia including diabetes. Diabetes Res Clin Pract. 2010; 88: 302-306. doi: 10.1016/j.diabres.2010.01.023 PMID: 20188429
14. Muller G, Parfentyeva E, Olschewsky J, Bornstein SR, Schwarz PEH Assessment of small fiber neuropathy to predict future risk of type 2 diabetes. Primary Care Diabetes 2013; 7: 269-273. doi: 10.1016/j.pcd.2013.08.001 PMID: 24076379
15. Mayaudon H, Miloche PO, Bauduceau B. A new simple method for assessing sudomotor function: relevance in type 2 diabetes. Diabetes and Metab. 2010; 36: 450-454.
16. Vinik SI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003; 26: 1553-1579. PMID: 12716821
17. Ozaki R, Cheung KK, Wu E, Kong A, Yang X, Lau E, et al. A new tool to detect kidney disease in Chinese type 2 diabetes patients - comparison of EZSCAN with standard screening methods. Diabetes Technol Ther. 2011; 13: 937-943. doi: 10.1089/dia.2011.0023 PMID: 21714678
18. Ko GT, So WY, Tong PC, Le Coguiec F, Kerr D, Lyubomirsky G, et al. From design to implementation - the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management program. BMC Med Inform Decis Mak. 2010; 10: 26. doi: 10.1186/1472-6947-10-26 PMID: 20465815
19. Chan J, So W, Ko G, Tong P, Yang X, Ma R, et al. The Joint Asia Diabetes Evaluation (JADE) program: a web-based program to translate evidence to clinical practice in type 2 diabetes. Diabet Med. 2009; 26: 693-699. doi: 10.1111/j.1464-5491.2009.02751.x PMID: 19573118
20. Ma YC, Zuo L, Chen JH, Luo Q, Yu ZQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2937-2944. PMID: 16988059
21. Luo KR, Chao CC, Hsieh PC, Lue JH, Hsieh ST. Effect of glycemic control on sudomotor denervation in type 2 diabetes. Diabetes Care 2012; 35: 612-616. doi: 10.2337/dc11-1607 PMID: 22301122
22. Sun K, Liu Y, Dai M, Li M, Yang Z, Xu M, et al. Assessing autonomic function can early screen metabolic syndrome. PLoSONE. 2012; 7(8): e43449. doi: 10.1371/journal.pone.0043449 PMID: 22916265
23. Illigens BMW, Gibbons CH. Sweat testing to evaluate autonomic function. Clinical Autonomic Research. 2009; 19: 79-87. doi: 10.1007/s10286-008-0506-8 PMID: 18989618
24. Yajnik CS, Kantikar VV, Pande AJ, Deslypere JP. Quick and simple evaluation of sudomotor function for screening of diabetic neuropathy. ISRN Endocrinol 2012: 103714 doi: 10.5402/2012/103714 PMID: 22830040
25. Casellini CM, Parson HK, Richardson MS, Nevoret ML, Vinik AI. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Techno Ther. 2013; 15: 948-953.
26. Freedman BI, Bowden DW, Smith SC, Xu J, Divers J. Relationships between electrochemical skin conductance and kidney disease in type 2 diabetes. J Diabetes Complications. 2014; 28: 56-60. doi: 10.1016/j.jdiacomp.2013.09.006 PMID: 24140119
27. Vinik A, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579. PMID: 12716821
28. MacIsaac RJ, Ekinci E, Jerums G. Progressive diabetic nephropathy. How useful is microalbuminuria?: Contra'. Kidney Inter 2014; 86: 50-57.
29. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Riskfactors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006; 55: 1832-1839. PMID: 16731850